Search

You searched for "innovation"

2660 results found

Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment

1 February 2015 | | EYE - Vitreo-Retinal, EYE - General
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...

Chronic dacryocystitis?

1 February 2018 | | EYE - General
Lacrimal drainage system tumours are rare and lymphomas account for less than 10% of these tumours [1]. Most patients presenting with lymphoma infiltration of the lacrimal drainage system have a history of previously diagnosed lymphoma elsewhere. We report a case...

Dementia and visual impairment: what is the relationship and are we providing the best care?

1 February 2022 | | EYE - Cataract, EYE - Refractive, EYE - General
Carla Maden discusses the implications of living with both dementia and visual impairment, and how general medical junior doctors and ophthalmologists can help to alleviate this burden and improve the quality of life of such patients. Dementia and visual impairment...
Retina journal front cover image.

Subfoveal choroidal thickness and PCV

1 April 2018 | | EYE - Vitreo-Retinal
This report studies the prognostic factors for visual improvement and the need for additional treatments at one year after the initial combination therapy of intravitreal ranibizumab injection or intravitreal aflibercept injection followed by PDT in eyes with PCV. Fifty-six eyes...
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY cover

Intracameral sodium hyaluronate for postoperative hypotony after Baerveldt glaucoma implant

1 June 2019 | | EYE - Glaucoma
This is a retrospective study to examine the effect of 0.1ml of sodium intracameral sodium hyaluronate 1.4% (Healon GV – HGV) in patients who had hypotony (IOP<5mmHg) within three months of having a Baerveldt glaucoma implant (BGI) operation. Hypotony is...
The New England Journal of Medicine cover image.

Persistence of Ebola virus in ocular fluid during convalescence

1 August 2015 | | EYE - Vitreo-Retinal
The most recent Ebola outbreak has infected over 26,300 patients, but also resulted in the highest number of survivors in history. Uveitis has been described during the convalescent period, but Varkey and colleagues report, for the first time, finding viable...

Refresh for ABDO College common room thanks to Millmead Optical Group

14 August 2023 | ABDO, Millmead Optical Group, College
Students at ABDO College will be able to relax in comfort and enjoy a refreshed common room thanks to Millmead Optical Group.

Her Royal Highness The Duchess of Edinburgh awarded Honorary Fellowship of The College of Optometrists for her outstanding contribution to eye health

22 October 2025 | The College of Optometrists, eye health, award, public awareness, optometry
The College of Optometrists has presented Her Royal Highness The Duchess of Edinburgh with an Honorary Fellowship of the College in recognition of Her Royal Highness’s outstanding contribution to eye health. The Duchess is passionate about preventing avoidable sight loss...

Diabetic retinopathy screening in Belize: a country’s journey towards reducing blindness from DR

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
The rise of diabetes mellitus (DM) and its complications is a public health concern in the Caribbean. The Caribbean Diabetic Retinopathy (DR) Programme, managed by the London School of Hygiene & Tropical Medicine (LSHTM) and funded by the Queen Elizabeth...

The ‘theatre of the mind’: Charles Bonnet Syndrome and Esme’s Umbrella

1 April 2019 | | EYE - Glaucoma, EYE - General
The founder of Esme’s Umbrella shares her experience with the poorly understood condition Charles Bonnet Syndrome and the creation of the campaign. Many years ago, when I was a young actress, I was in an American play called ‘Butterflies are...

Clinical trial investigates ‘Light Touch’ approach to wet AMD treatment

20 October 2025 | NIHR, Treatment, Retina, neovascularisation, vision
A clinical trial led by NIHR Moorfields Clinical Research Facility will explore a new ‘light-touch’ treatment approach for patients with neovascular age-related macular degeneration (wet AMD) that could result in fewer injections and reduced number of clinic visits. Funded by...

Aug/Sep 2014 Quiz 2

1 August 2014 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
History A 27-year-old man presented to the emergency department with blurred vision and central scotoma in the right eye (RE) over the previous weeks. He had no relevant medical history and he was not on any current medication. However, he...